Why the Certificate of Analysis Matters for Reproducibility
A certificate of analysis (COA) is the primary documented evidence of a specific research peptide batch’s identity and purity, and understanding how to read it properly is essential for any laboratory aiming for reproducible experimental results. Variability in peptide quality between suppliers, or even between batches from the same supplier, is a documented contributor to irreproducibility in published research, making careful COA review a meaningful part of good laboratory practice rather than a purely administrative formality.
Laboratories that skip this review step, treating any peptide meeting a general product description as interchangeable, risk building experimental conclusions on inputs that were never actually verified to the standard the research question requires.
Key Fields to Check
A complete COA should identify the specific batch or lot number matching the physical product received, report HPLC purity as a specific percentage alongside the test method used, and confirm molecular identity through mass spectrometry data matching the theoretical molecular weight calculated from the peptide’s sequence. Researchers should independently verify that the reported molecular weight matches their own calculation for the sequence, as a simple but effective cross-check against a documentation or labeling error.
Additional fields worth reviewing, where relevant to the specific research application, include counter-ion content for peptides supplied as a salt form, residual solvent levels, and water or moisture content, since this last figure particularly affects accurate mass-based concentration calculations when preparing solutions for an experiment.
Recognizing an Incomplete or Questionable Certificate
A COA that reports only a summary purity percentage without any accompanying method reference, chromatogram, or mass spectrometry confirmation provides considerably less assurance than a complete documentation package, and researchers working on sensitive or high-stakes studies should request the full underlying data rather than accepting a bare summary figure. Certificates that appear identical in format and figures across multiple different batches or even different peptides from the same supplier warrant particular scrutiny, since genuine batch-specific testing data typically shows natural variation.
When a COA raises questions that a supplier cannot satisfactorily answer, sourcing the material from a different, more transparent supplier is generally a better use of research time than proceeding with material of uncertain documented quality.
Retaining COAs as Part of the Research Record
Systematically filing and retaining COAs for every peptide batch used in a study supports both good laboratory practice and the reproducibility expectations increasingly emphasized by journals and funding bodies, allowing a specific study’s methods section to reference verifiable, batch-specific quality documentation rather than only a general product description. This record also proves valuable if a later study attempts to replicate results and needs to compare the material used across both efforts.
Institutions running multiple concurrent studies benefit from a centralized system for organizing COAs by peptide, batch, and associated study, rather than leaving this documentation scattered across individual researchers’ personal files, which becomes difficult to locate and audit as lab personnel and projects change over time.